Targeting chemokine receptor CXCR7 inhibits glioma cell proliferation and mobility.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The functional contribution of chemokine receptor CXCR7 to malignant brain tumor biology remains controversial.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Anticancer Res.

Title: Anticancer research

ISSN (Electronic): 1791-7530

ISSN (Print): 0250-7005

Publication date (Electronic): Jan 2015

Volume: 35

Issue: 1

Affiliations

[1 ] Department of Neurosurgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, U.S.A. yang_liu@urmc.rochester.edu kevin_walter@urmc.rochester.edu.

[2 ] Department of Neurosurgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, U.S.A.

[3 ] Department of Neurosurgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, U.S.A. Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY, U.S.A. yang_liu@urmc.rochester.edu kevin_walter@urmc.rochester.edu.